Literature DB >> 7292252

Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19.

G Koch, P A Lalley, M McAvoy, T B Shows.   

Abstract

The genetics of lysosomal acid lipase (LIP) has been investigated in human-Chinese hamster and mouse-Chinese hamster somatic cell hybrids. Cellulose acetate electrophoresis of human fibroblast extracts demonstrated that LIP activity consists of three isozymes. A deficiency of LIP activity has been observed in Wolman's disease (WD), cholesterol ester storage disease (CESD), and I-cell disease (ICD); this deficiency was associated with only one LIP isozyme, LIPA. We have demonstrated concordant segregation between human LIPA and human chromosome 10 and its enzyme marker glutamate oxaloacetate transaminase-1 (GOT1) in cell hybrid clones. Previous evidence suggested the different mutations associated with WD and CESD to be in the structural gene which we assign to human chromosome 10, while a different gene, involved in the processing of LIPA, is altered in ICD. These results indicate that several types of gene products are involved in the final expression of LIPA. In mouse-Chinese hamster hybrid clones, mouse Lip-1 (homologous to human LIPA) was assigned to chromosome 19. Previously, mouse Got-1 has been assigned to chromosome 19. Thus, the LIPA-GOT1 linkage groups has remained intact during the 80 X 10(6) years of evolution that separates humans and mice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7292252     DOI: 10.1007/bf01538859

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  10 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Mouse chromosome 19.

Authors:  J L Guénet
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 3.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

4.  Intragenic deletion as a novel type of mutation in Wolman disease.

Authors:  Teresa M Lee; Mariko Welsh; Sonia Benhamed; Wendy K Chung
Journal:  Mol Genet Metab       Date:  2011-09-14       Impact factor: 4.797

5.  Esterase-18 (ES-18) of the house mouse (Mus musculus): biochemical characterization and genetics of an allozyme system linked to chromosome 19.

Authors:  O H von Deimling; A Gaa; M M Simon
Journal:  Biochem Genet       Date:  1988-10       Impact factor: 1.890

6.  A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

Authors:  H Klima; K Ullrich; C Aslanidis; P Fehringer; K J Lackner; G Schmitz
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  The gene coding for a sphingolipid activator protein, SAP-1, is on human chromosome 10.

Authors:  K Inui; F T Kao; S Fujibayashi; C Jones; H G Morse; M L Law; D A Wenger
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease.

Authors:  Venu T Tadiboyina; Dora M Liu; Brooke A Miskie; Jian Wang; Robert A Hegele
Journal:  Lipids Health Dis       Date:  2005-10-28       Impact factor: 3.876

9.  Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H).

Authors:  Roger S Holmes; John L Vandeberg; Laura A Cox
Journal:  3 Biotech       Date:  2011-08-03       Impact factor: 2.406

10.  Gene co-expression networks are associated with obesity-related traits in kidney transplant recipients.

Authors:  Rosario B Jaime-Lara; Abhrarup Roy; Yupeng Wang; Ansley Stanfill; Ann K Cashion; Paule V Joseph
Journal:  BMC Med Genomics       Date:  2020-03-10       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.